Patents by Inventor Philip FREIDENREICH

Philip FREIDENREICH has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Methods and compositions for safe and effective treatment of erythema
    Patent number: 9861632
    Abstract: Improved methods and compositions for safe and effective treatment of erythema or a symptom associated with erythema in a subject are described. The methods involve topically applying to an affected skin area a topical composition comprising about 0.3% to about 10% by weight of brimonidine and a pharmaceutically acceptable carrier.
    Type: Grant
    Filed: December 14, 2015
    Date of Patent: January 9, 2018
    Assignee: Galderma Laboratories, L.P.
    Inventors: Michael Graeber, Christian Loesche, Philip Freidenreich, Yin-sang Liu, Matthew James Leoni
  • Methods and compositions for safe and effective treatment of erythema
    Patent number: 9861631
    Abstract: Improved methods and compositions for safe and effective treatment of erythema or a symptom associated with erythema in a subject are described. The methods involve topically applying to an affected skin area a topical composition comprising about 0.3% to about 10% by weight of brimonidine and a pharmaceutically acceptable carrier.
    Type: Grant
    Filed: April 6, 2015
    Date of Patent: January 9, 2018
    Assignee: Galderma Laboratories, L.P.
    Inventors: Michael Graeber, Christian Loesche, Philip Freidenreich, Yin-sang Liu, Matthew James Leoni
  • METHODS AND COMPOSITIONS FOR TREATING OR PREVENTING ERYTHEMA
    Publication number: 20170296535
    Abstract: Methods and products for treating or preventing erythema or a symptom associated with erythema in a subject are described. The methods involve topically applying to an affected skin area a topical aqueous gel composition comprising about 0.01% to about 10% by weight of at least one ?-adrenergic receptor agonist and a pharmaceutically acceptable carrier.
    Type: Application
    Filed: June 28, 2017
    Publication date: October 19, 2017
    Inventors: Michael GRAEBER, Christian LOESCHE, Philip FREIDENREICH, Jack A. DEJOVIN, Isabelle Jean DEJOVIN, Yin-sang LIU, Matthew James LEONI
  • METHODS AND COMPOSITIONS FOR TREATING OR PREVENTING ERYTHEMA
    Publication number: 20170087085
    Abstract: Methods and products for treating or preventing erythema or a symptom associated with erythema in a subject are described. The methods involve topically applying to an affected skin area a topical aqueous gel composition comprising about 0.01% to about 10% by weight of at least one ?-adrenergic receptor agonist and a pharmaceutically acceptable carrier.
    Type: Application
    Filed: December 8, 2016
    Publication date: March 30, 2017
    Inventors: Michael GRAEBER, Christian LOESCHE, Philip FREIDENREICH, Jack A. DEJOVIN, Isabelle Jean DEJOVIN, Yin-sang LIU, Matthew James LEONI
  • METHODS AND COMPOSITIONS FOR SAFE AND EFFECTIVE TREATMENT OF ERYTHEMA
    Publication number: 20160095857
    Abstract: Improved methods and compositions for safe and effective treatment of erythema or a symptom associated with erythema in a subject are described. The methods involve topically applying to an affected skin area a topical composition comprising about 0.3% to about 10% by weight of brimonidine and a pharmaceutically acceptable carrier.
    Type: Application
    Filed: December 14, 2015
    Publication date: April 7, 2016
    Inventors: Michael GRAEBER, Christian LOESCHE, Philip FREIDENREICH, Yin-sang LIU, Matthew James LEONI
  • METHODS AND COMPOSITIONS FOR TREATING OR PREVENTING ERYTHEMA
    Publication number: 20160008355
    Abstract: Methods and products for treating or preventing erythema or a symptom associated with erythema in a subject are described. The methods involve topically applying to an affected skin area a topical aqueous gel composition comprising about 0.01% to about 10% by weight of at least one ?-adrenergic receptor agonist and a pharmaceutically acceptable carrier.
    Type: Application
    Filed: September 23, 2015
    Publication date: January 14, 2016
    Inventors: Michael GRAEBER, Christian LOESCHE, Philip FREIDENREICH, Jack A. DEJOVIN, Isabelle Jean DEJOVIN, Yin-sang LIU, Matthew James LEONI
  • METHODS AND COMPOSITIONS FOR SAFE AND EFFECTIVE TREATMENT OF ERYTHEMA
    Publication number: 20150209350
    Abstract: Improved methods and compositions for safe and effective treatment of erythema or a symptom associated with erythema in a subject are described. The methods involve topically applying to an affected skin area a topical composition comprising about 0.3% to about 10% by weight of brimonidine and a pharmaceutically acceptable carrier.
    Type: Application
    Filed: April 6, 2015
    Publication date: July 30, 2015
    Inventors: Michael GRAEBER, Christian LOESCHE, Philip FREIDENREICH, Yin-sang LIU, Matthew James LEONI
  • Methods and compositions for safe and effective treatment of telangiectasia
    Patent number: 8916562
    Abstract: Improved methods and compositions for safe and effective treatment of telangiectasia or a symptom associated with telangiectasia in a subject are described. The methods involve topically applying to an affected skin area a topical composition comprising about 0.3% to about 10% by weight of brimonidine and a pharmaceutically acceptable carrier.
    Type: Grant
    Filed: March 25, 2011
    Date of Patent: December 23, 2014
    Assignee: Galderma Research & Development SNC
    Inventors: Michael Graeber, Christian Loesche, Philip Freidenreich, Yin Liu, Matthew James Leoni
  • METHOD OF TREATING ACNE
    Publication number: 20140309198
    Abstract: An improved method for treating acne is described. The method involves 16-week, once daily, oral administration of about 40 mg doxycycline in a pharmaceutical composition containing about 30 mg doxycycline in an immediate release portion and about 10 mg doxycycline in a delayed release portion. It was surprisingly discovered that the 16-week, once daily, oral administration of about 40 mg doxycycline has achieved same or superior efficacy than that of 100 mg doxycycline, but with a significant reduction in adverse events.
    Type: Application
    Filed: April 4, 2014
    Publication date: October 16, 2014
    Inventors: Vasant Kumar MANNA, Sandrine SEGURA, Ludovic BUSSARD, Jean-Pierre ETCHEGARAY, Philip FREIDENREICH
  • METHODS AND COMPOSITIONS FOR SAFE AND EFFECTIVE TREATMENT OF ERYTHEMA
    Publication number: 20140094469
    Abstract: Improved methods and compositions for safe and effective treatment of erythema or a symptom associated with erythema in a subject are described. The methods involve topically applying to an affected skin area a topical composition comprising about 0.3% to about 10% by weight of brimonidine and a pharmaceutically acceptable carrier.
    Type: Application
    Filed: December 5, 2013
    Publication date: April 3, 2014
    Applicant: GALDERMA RESEARCH & DEVELOPMENT
    Inventors: Michael GRAEBER, Christian LOESCHE, Philip FREIDENREICH, Yin-sang LIU, Matthew James LEONI
  • METHODS AND COMPOSITIONS FOR TREATING OR PREVENTING ERYTHEMA
    Publication number: 20140080836
    Abstract: Methods and products for treating or preventing erythema or a symptom associated with erythema in a subject are described. The methods involve topically applying to an affected skin area a topical aqueous gel composition comprising about 0.01% to about 10% by weight of at least one ?-adrenergic receptor agonist and a pharmaceutically acceptable carrier.
    Type: Application
    Filed: November 19, 2013
    Publication date: March 20, 2014
    Applicant: GALDERMA LABORATORIES INC.
    Inventors: Michael GRAEBER, Christian LOESCHE, Philip FREIDENREICH, Jack A. DEJOVIN, Isabelle Jean DEJOVIN, Yin-sang LIU, Matthew James LEONI
  • Methods and compositions for treating or preventing erythema
    Patent number: 8586586
    Abstract: Methods and products for treating or preventing erythema or a symptom associated with erythema in a subject are described. The methods involve topically applying to an affected skin area a topical aqueous gel composition comprising about 0.01% to about 10% by weight of at least one ?-adrenergic receptor agonist and a pharmaceutically acceptable carrier.
    Type: Grant
    Filed: March 8, 2013
    Date of Patent: November 19, 2013
    Assignee: Galderma Laboratories Inc.
    Inventors: Michael Graeber, Christian Loesche, Philip Freidenreich, Jack A. DeJovin, Isabelle Jean DeJovin, Yin-sang Liu, Matthew James Leoni
  • Methods and compositions for safe and effective treatment of erythema
    Patent number: 8513249
    Abstract: Improved methods and compositions for safe and effective treatment of erythema or a symptom associated with erythema in a subject are described. The methods involve topically applying to an affected skin area a topical composition comprising about 0.4% to about 0.6% by weight of brimonidine and a pharmaceutically acceptable carrier.
    Type: Grant
    Filed: April 26, 2012
    Date of Patent: August 20, 2013
    Assignee: Galderma Laboratories, L.P.
    Inventors: Michael Graeber, Christian Loesche, Philip Freidenreich, Yin-Sang Liu, Matthew J. Leoni
  • Methods and compositions for safe and effective treatment of erythema
    Patent number: 8513247
    Abstract: Improved methods and compositions for safe and effective treatment of erythema or a symptom associated with erythema in a subject are described. The methods involve topically applying to an affected skin area a topical composition comprising about 0.4% to about 0.6% by weight of brimonidine and a pharmaceutically acceptable carrier.
    Type: Grant
    Filed: March 25, 2011
    Date of Patent: August 20, 2013
    Assignee: Galderma Laboratories, L.P.
    Inventors: Michael Graeber, Christian Loesche, Philip Freidenreich, Yin-Sang Liu, Matthew J. Leoni
  • Methods and compositions for treating or preventing erythema
    Patent number: 8410102
    Abstract: Methods and products for treating or preventing erythema or a symptom associated with erythema in a subject are described. The methods involve topically applying to an affected skin area a topical aqueous gel composition comprising about 0.01% to about 10% by weight of at least one ?-adrenergic receptor agonist and a pharmaceutically acceptable carrier.
    Type: Grant
    Filed: March 25, 2011
    Date of Patent: April 2, 2013
    Assignee: Galderma Laboratories Inc.
    Inventors: Michael Graeber, Christian Loesche, Philip Freidenreich, Jack A. Dejovin, Isabelle Jean Dejovin, Yin-Sang Liu, Matthew James Leoni
  • METHODS AND COMPOSITIONS FOR SAFE AND EFFECTIVE TREATMENT OF ERYTHEMA
    Publication number: 20130071489
    Abstract: Improved methods and compositions for safe and effective treatment of erythema or a symptom associated with erythema in a subject are described. The methods involve topically applying to an affected skin area a topical composition comprising about 0.3% to about 10% by weight of brimonidine and a pharmaceutically acceptable carrier.
    Type: Application
    Filed: March 25, 2011
    Publication date: March 21, 2013
    Applicant: GALDERMA RESEARCH & DEVELOPMENT SNC
    Inventors: Michael Graeber, Christian Loesche, Philip Freidenreich, Yin Liu, Matthew James Leoni
  • METHODS AND COMPOSITIONS FOR SAFE AND EFFECTIVE TREATMENT OF TELANGIECTASIA
    Publication number: 20130059857
    Abstract: Improved methods and compositions for safe and effective treatment of telangiectasia or a symptom associated with telangiectasia in a subject are described. The methods involve topically applying to an affected skin area a topical composition comprising about 0.3% to about 10% by weight of brimonidine and a pharmaceutically acceptable carrier.
    Type: Application
    Filed: March 25, 2011
    Publication date: March 7, 2013
    Applicant: GALDERMA RESEARCH & DEVELOPMENT SNC
    Inventors: Michael Graeber, Christian Loesche, Philip Freidenreich, Yin Liu, Matthew James Leoni
  • METHODS AND COMPOSITIONS FOR SAFE AND EFFECTIVE TREATMENT OF ERYTHEMA
    Publication number: 20120214816
    Abstract: Improved methods and compositions for safe and effective treatment of erythema or a symptom associated with erythema in a subject are described. The methods involve topically applying to an affected skin area a topical composition comprising about 0.4% to about 0.6% by weight of brimonidine and a pharmaceutically acceptable carrier.
    Type: Application
    Filed: April 26, 2012
    Publication date: August 23, 2012
    Applicant: Galdema R&D Inc.
    Inventors: Michael GRAEBER, Christian LOESCHE, Philip FREIDENREICH, Yin-Sang LIU, Matthew J. LEONI
  • METHODS AND COMPOSITIONS FOR TREATING OR PREVENTING ERYTHEMA
    Publication number: 20110288096
    Abstract: Methods and products for treating or preventing erythema or a symptom associated with erythema in a subject are described. The methods involve topically applying to an affected skin area a topical aqueous gel composition comprising about 0.01% to about 10% by weight of at least one ?-adrenergic receptor agonist and a pharmaceutically acceptable carrier.
    Type: Application
    Filed: March 25, 2011
    Publication date: November 24, 2011
    Applicant: GALDERMA LABORATORIES INC.
    Inventors: Michael GRAEBER, Christian LOESCHE, Philip FREIDENREICH, Jack A. DEJOVIN, Isabelle Jean DEJOVIN, Yin-Sang LIU, Matthew J. LEONI
  • METHODS AND COMPOSITIONS FOR SAFE AND EFFECTIVE TREATMENT OF ERYTHEMA
    Publication number: 20110286944
    Abstract: Improved methods and compositions for safe and effective treatment of erythema or a symptom associated with erythema in a subject are described. The methods involve topically applying to an affected skin area a topical composition comprising about 0.4% to about 0.6% by weight of brimonidine and a pharmaceutically acceptable carrier.
    Type: Application
    Filed: March 25, 2011
    Publication date: November 24, 2011
    Applicant: GALDERMA R&D INC.
    Inventors: Michael GRAEBER, Christian LOESCHE, Philip FREIDENREICH, Yin-Sang LIU, Matthew J. LEONI